Solanbridge Group, Inc. (SLNX)
Solanbridge Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Lakewood, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $476,000. On trailing twelve-month figures it carries a trailing P/E of -7.14, a net margin of 0.0%. Its beta of -6.84 implies it has historically moved less than the broad market.
Solanbridge Group, Inc. concentrates its efforts on cultivating and marketing medical cannabis in Nova Scotia, Canada. Additionally, the organization is committed to developing and distributing a range of CBD-enriched products throughout Nevada, California, and Colorado. The enterprise was founded in 2000 and maintains its main corporate offices in The Woodlands, Texas.
Solanbridge Group, Inc. is most often compared with the following Healthcare names: